首页> 外文期刊>Journal of laparoendoscopic and advanced surgical techniques, Part A >Minimally Invasive Surgery for Rectal Adenocarcinoma Shows Promising Outcomes Compared to Laparotomy, a National Cancer Database Observational Analysis
【24h】

Minimally Invasive Surgery for Rectal Adenocarcinoma Shows Promising Outcomes Compared to Laparotomy, a National Cancer Database Observational Analysis

机译:直肠腺癌的微创手术显示出与剖腹术相比,国家癌症数据库观测分析相比表现出有希望的结果

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Purpose/Background: The surgical approach to adenocarcinoma of the rectum remains a controversial topic. Although current data focus on the noninferiority of minimally invasive surgery (MIS) for rectal cancer compared with laparotomy, conclusions are drawn from smaller sample sizes and may be underpowered. Methods/Interventions: The National Cancer Database (NCDB) from 2010 to 2014 was reviewed for all cases of invasive adenocarcinoma of the rectum (SEER Histology Codes 8140) who underwent surgical resection for malignancy. Groups were separated based on laparotomy or an MIS approach and stratified by NCDB Analytic Stage. Multivariate Cox regression analysis was used to evaluate for survival after diagnosis of adenocarcinoma of the rectum. Results/Outcomes: The inclusion criteria identified 29,199 cases of adenocarcinoma of the rectum managed surgically. After controlling for differences in the cohorts, survival after diagnosis and definitive surgical treatment for adenocarcinoma of the rectum is improved when an MIS approach was used (adjusted hazard ratio [HR] = 0.82, 95% confidence interval [CI] = 0.77–0.88, P P P 12 (73.2% versus 70.1%, P Conclusion/Discussion: Minimally invasive resection for adenocarcinoma of the rectum shows promising survival benefit compared with open surgery after adjusting for measured confounds.
机译:目的/背景:直肠腺癌的外科手术方法仍然是一个有争议的话题。尽管与剖腹谱比较的直肠癌相比,目前的数据专注于直肠癌的微创手术(MIS),但从较小的样品尺寸中抽出结论,并且可能是动力的。方法/干预措施:对2010年至2014年的国家癌症数据库(NCDB)对直肠(SER组织学代表8140)的所有侵袭性腺癌患者进行了审查,他接受了恶性肿瘤的外科切除。基于剖腹手术或MIS方法分离群体,并通过NCDB分析阶段分层。多变量Cox回归分析用于评估直肠腺癌诊断后的存活。结果/结果:纳入标准确定了29.199例外肠癌腺癌患者。在控制群体差异后,诊断后的存活和直肠腺癌的腺癌外科治疗得到改善(调整后危险比[HR] = 0.82,95%置信区间[CI] = 0.77-0.88, PPP 12(73.2%对70.1%,P结论/讨论:对直肠腺癌的微创切除表现出有希望的存活效益与调整测量混淆后的开放手术相比。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号